161 related articles for article (PubMed ID: 12462026)
21. Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
Deeg HJ; Jiang PY; Holmberg LA; Scott B; Petersdorf EW; Appelbaum FR
Leuk Res; 2004 Nov; 28(11):1177-80. PubMed ID: 15380342
[TBL] [Abstract][Full Text] [Related]
22. [Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
Chen SC; Jiang B; Da WM; Gong M; Guan M
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2711-5. PubMed ID: 17199984
[TBL] [Abstract][Full Text] [Related]
23. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
[TBL] [Abstract][Full Text] [Related]
24. The role of the immune system in myelodysplasia: implications for therapy.
Sloand EM; Rezvani K
Semin Hematol; 2008 Jan; 45(1):39-48. PubMed ID: 18179968
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
Biesma DH; van den Tweel JG; Verdonck LF
Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
Goldenberg NA; Graham DK; Liang X; Hays T
Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
[TBL] [Abstract][Full Text] [Related]
27. Quality of hematologic recovery in patients with aplastic anemia following cyclosporine therapy.
Yamaguchi M; Nakao S; Takamatsu H; Chuhjo T; Shiobara S; Matsuda T
Exp Hematol; 1995 Apr; 23(4):341-6. PubMed ID: 7534714
[TBL] [Abstract][Full Text] [Related]
28. Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome.
Berer A; Ohler L; Simonitsch I; Thalhammer R; Lechner K; Geissler K
Wien Klin Wochenschr; 1999 Oct; 111(19):815-8. PubMed ID: 10568013
[TBL] [Abstract][Full Text] [Related]
29. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
Matsuo Y; Iwanaga M; Mori H; Yoshida S; Kawaguchi Y; Yakata Y; Murata K; Nagai K; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
[TBL] [Abstract][Full Text] [Related]
30. Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
Orimoto M; Maeda M; Cai LZ; Hayakawa J; Ueda T; Migita M; Asano T
Med Pediatr Oncol; 2003 May; 40(5):334-5. PubMed ID: 12652627
[No Abstract] [Full Text] [Related]
31. A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders.
Gupta V; Gordon-Smith EC; Cook G; Parker A; Duguid JK; Wilson KM; Yi QL; Marsh JC
Br J Haematol; 2005 Apr; 129(1):110-7. PubMed ID: 15801963
[TBL] [Abstract][Full Text] [Related]
32. [Immunosuppressive therapy with antithymocyte globulin and cyclosporine for paroxysmal nocturnal hemoglobinuria].
Nakasone H; Iijima K; Asano H; Nakamura F; Kida M; Izutsu K; Urabe A; Usuki K
Rinsho Ketsueki; 2008 Jul; 49(7):498-504. PubMed ID: 18709982
[TBL] [Abstract][Full Text] [Related]
33. Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment.
Barrett J; Sloand E; Young N
Haematologica; 2006 May; 91(5):583-4. PubMed ID: 16670061
[No Abstract] [Full Text] [Related]
34. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
[TBL] [Abstract][Full Text] [Related]
35. Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
Cazzola M
Int J Hematol; 2000 Aug; 72(2):134-8. PubMed ID: 11039660
[TBL] [Abstract][Full Text] [Related]
36. [Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia].
Zheng Y; Chu Y; Shao Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Apr; 20(4):175-7. PubMed ID: 11601221
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
Fang JP; Xu HG; Huang SL; Chen C; Huang K
Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
[TBL] [Abstract][Full Text] [Related]
38. Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).
Hasegawa D; Manabe A; Yagasaki H; Ohtsuka Y; Inoue M; Kikuchi A; Ohara A; Tsuchida M; Kojima S; Nakahata T;
Pediatr Blood Cancer; 2009 Dec; 53(6):1011-5. PubMed ID: 19499580
[TBL] [Abstract][Full Text] [Related]
39. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.
Saracco P; Quarello P; Iori AP; Zecca M; Longoni D; Svahn J; Varotto S; Del Vecchio GC; Dufour C; Ramenghi U; Bacigalupo A; Locasciulli A;
Br J Haematol; 2008 Jan; 140(2):197-205. PubMed ID: 18173756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
